These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38795660)

  • 21. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
    Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building.
    Sherer EA; Sale ME; Pollock BG; Belani CP; Egorin MJ; Ivy PS; Lieberman JA; Manuck SB; Marder SR; Muldoon MF; Scher HI; Solit DB; Bies RR
    J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):393-414. PubMed ID: 22767341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen.
    Loisios-Konstantinidis I; Cristofoletti R; Jamei M; Turner D; Dressman J
    Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33147873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Pharmacokinetic/Pharmacodynamic Analysis of the Glucokinase Activator PB201 in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus: Facilitating the Clinical Development of PB201 in China.
    Song L; Cao F; Niu S; Xu M; Liang R; Ding K; Lin Z; Yao X; Liu D
    Clin Pharmacokinet; 2024 Jan; 63(1):93-108. PubMed ID: 37985591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effects.
    Mandema JW; Verotta D; Sheiner LB
    J Pharmacokinet Biopharm; 1992 Oct; 20(5):511-28. PubMed ID: 1287200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic/pharmacodynamic modeling in drug research and development.
    Derendorf H; Lesko LJ; Chaikin P; Colburn WA; Lee P; Miller R; Powell R; Rhodes G; Stanski D; Venitz J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1399-418. PubMed ID: 11185661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Critique of Computer Simulation Software's Used in Pharmacokinetics and Pharmacodynamics Analysis.
    Dave V; Yadav RB; Yadav S; Sharma S; Sahu RK; Ajayi AF
    Curr Clin Pharmacol; 2018; 13(4):216-235. PubMed ID: 30360723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population Pharmacokinetic and Pharmacodynamic Modeling and Effects on Platelet Counts of Different Dosages of Eltrombopag in Chinese Patients With Chronic Primary Immune Thrombocytopenia.
    Wu K; Thapar M; Farrell C; Hayes S; Guo H; Hou M; Zhang J
    Clin Ther; 2015 Jul; 37(7):1382-95. PubMed ID: 25929594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling.
    Wang J; Edginton AN; Avant D; Burckart GJ
    J Clin Pharmacol; 2015 Oct; 55(10):1175-83. PubMed ID: 25907280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics/pharmacodynamics model-supported early drug development.
    Chen B; Dong JQ; Pan WJ; Ruiz A
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1360-75. PubMed ID: 22201585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of In Vivo Pharmacokinetic Parameters and Time-Exposure Curves in Rats Using Machine Learning from the Chemical Structure.
    Obrezanova O; Martinsson A; Whitehead T; Mahmoud S; Bender A; Miljković F; Grabowski P; Irwin B; Oprisiu I; Conduit G; Segall M; Smith GF; Williamson B; Winiwarter S; Greene N
    Mol Pharm; 2022 May; 19(5):1488-1504. PubMed ID: 35412314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adoption of Machine Learning in Pharmacometrics: An Overview of Recent Implementations and Their Considerations.
    Janssen A; Bennis FC; Mathôt RAA
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics/pharmacodynamics of anesthetics.
    Olofsen E; Dahan A
    AAPS J; 2005 Oct; 7(2):E383-9. PubMed ID: 16353918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.
    Ayyar VS; Jusko WJ
    Pharmacol Rev; 2020 Apr; 72(2):414-438. PubMed ID: 32123034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving predictive modeling in pediatric drug development: pharmacokinetics, pharmacodynamics, and mechanistic modeling.
    Slikker W; Young JF; Corley RA; Dorman DC; Conolly RB; Knudsen TB; Erstad BL; Luecke RH; Faustman EM; Timchalk C; Mattison DR
    Ann N Y Acad Sci; 2005 Aug; 1053():505-18. PubMed ID: 16179559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period.
    Dong M; Fukuda T; Cox S; de Vries MT; Hooper DK; Goebel J; Vinks AA
    Br J Clin Pharmacol; 2014 Nov; 78(5):1102-12. PubMed ID: 24837828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population Pharmacokinetics/Pharmacodynamics of Ticagrelor in Children with Sickle Cell Disease.
    Amilon C; Niazi M; Berggren A; Åstrand M; Hamrén B
    Clin Pharmacokinet; 2019 Oct; 58(10):1295-1307. PubMed ID: 30972696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Another string to your bow: machine learning prediction of the pharmacokinetic properties of small molecules.
    Bassani D; Parrott NJ; Manevski N; Zhang JD
    Expert Opin Drug Discov; 2024 Jun; 19(6):683-698. PubMed ID: 38727016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population Pharmacokinetic-Pharmacodynamic Modeling of Inotersen, an Antisense Oligonucleotide for Treatment of Patients with Hereditary Transthyretin Amyloidosis.
    Yu RZ; Collins JW; Hall S; Ackermann EJ; Geary RS; Monia BP; Henry SP; Wang Y
    Nucleic Acid Ther; 2020 Jun; 30(3):153-163. PubMed ID: 32286934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PK/PD modeling of 5-hydroxytryptophan (5-HTP) challenge test with cortisol measurement in serum and saliva.
    Guan Z; Jacobs G; van Pelt H; Van Gerven JMA; Burggraaf J; Zhao W
    Pharmacol Res Perspect; 2020 Apr; 8(2):e00574. PubMed ID: 32168433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.